Perrigo (NYSE:PRGO) Releases FY25 Earnings Guidance

Perrigo (NYSE:PRGO) updated its FY25 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $2.90-3.10 for the period, compared to the consensus estimate of $3.01. The company issued revenue guidance of +1-3% yr/yr to $4.42-4.51 billion, compared to the consensus revenue estimate of $4.62 billion. Perrigo also updated its FY 2025 guidance to 2.900-3.100 EPS.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on PRGO shares. StockNews.com downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Argus downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Finally, Piper Sandler downgraded shares of Perrigo from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $34.00 to $27.00 in a report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Perrigo currently has a consensus rating of “Hold” and an average target price of $35.00.

Perrigo Price Performance

Shares of Perrigo stock traded up $4.84 on Friday, hitting $28.97. 5,591,047 shares of the company were exchanged, compared to its average volume of 1,489,145. The stock has a market capitalization of $3.95 billion, a price-to-earnings ratio of -24.78 and a beta of 0.54. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The company has a 50-day moving average price of $24.87 and a 200 day moving average price of $26.18. Perrigo has a 1-year low of $23.14 and a 1-year high of $33.46.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, topping analysts’ consensus estimates of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.20 billion. As a group, sell-side analysts predict that Perrigo will post 2.56 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th will be given a dividend of $0.29 per share. The ex-dividend date is Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.00%. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s dividend payout ratio is currently -99.15%.

Insider Buying and Selling

In related news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the completion of the transaction, the director now directly owns 5,409 shares of the company’s stock, valued at $152,912.43. This represents a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.40% of the company’s stock.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.